# A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects

> **NCT02536209** · PHASE1 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 20 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MT-8554 low dose
- **DRUG:** MT-8554 high dose
- **DRUG:** Oxycodone hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02536209
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02536209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02536209, "A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02536209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*